Today in 5 Lines
Senate Majority Leader Mitch McConnell announced that the Senate will not vote on the new GOP health-care bill until after the July 4 recess. During a meeting with Republican senators, President Trump said he hopes the bill can pass, adding that, “if we don’t get it done, it’s just going to be something that we’re not going to like. And that’s okay, and I understand that very well.” The Pentagon said it has seen chemical-weapons activity at an airfield in Syria—a day after the White House released a statement issuing a warning to Syria. Three current or former Chicago police officers were indicted for allegedly trying to obscure the details of the death of Laquan McDonald, a black teenager shot by an officer in 2014. The Department of Homeland Security said it is “coordinating with our international and domestic cyber partners” after at least six countries were hit by a cyberattack.
- President Donald Trump was largely on the sidelines while his administration urged Republican senators to back their chamber’s health care bill, leaving the heavy lifting to Vice President Mike Pence. Majority Leader Mitch McConnell (Ky.) and other GOP senators told the president at a Tuesday meeting that they were irked by a Trump-aligned super PAC attacking Sen. Dean Heller (R-Nev.) for his opposition to the legislation. (The New York Times)
- Fifty-three percent of voters say they oppose the Medicaid cuts in the Senate’s health care bill, one of many sticking points among Republicans that led McConnell to delay a vote planned for this week. (Morning Consult)
- John Podesta, Hillary Clinton’s former campaign chairman whose emails were hacked in 2016, met privately with the House Intelligence Committee. He defended the Obama administration’s response to Russian attempts to meddle in the contest amid criticism that it didn’t do enough to retaliate. (Bloomberg News)
- Rep. Chris Collins (R-N.Y.), who is being investigated by the Office of Congressional Ethics for passing along a stock tip to other lawmakers, faces a financial loss after the Australian biomedical company’s stock he promoted plunged 92 percent on news that a clinical trial failed. One of the lawmakers who purchased shares in the company – Health and Human Services Secretary Tom Price (R), who was previously a member of Georgia’s delegation in the House – sold his shares in February. (The Wall Street Journal)